Riskpilot← Back to searchSign inGet full accessLaestadius Läkarkonsult AB
ABActiveOrg 5568891609Rödhakevägen 13Medical specialists activities · NACE 8622Est. 20120 employees
Revenue 2025
—
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit 2025
—
0 employees
| Revenue | — | — |
| EBITDA | SEK 0 | — |
| Net profit | — | — |
| Total assets | — | — |
| Equity | — | — |
| Employees | 0 | — |
Legal name
Laestadius Läkarkonsult AB
Org number
5568891609
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
29 mars 2012
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-01-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för företagets verksamhet är läkarkonsultverksamhet inom hälso- och sjukvård samt därmed förenlig verksamhet. Styling och renovering av lägenheter inför försäljning. Småskalig restaurangverksamhet såsom pop-up restaurang. Handel med värdepapper, konst och ädelmetaller. Arrangera och genomföra konst- och vandringsresor. Bedriva trädgårdsskötsel.
Address
Rödhakevägen 13
Email
a.laestadius@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 89 | 92 | 0 | — |
| Staff expenses | — | — | — | — | — |
| EBITDA | −215 | −666 | −601 | −911 | 0 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | — |
| EBIT | −215 | −666 | −601 | −911 | 0 |
| Net financials | 230 | 1 271 | 1 511 | 1 658 | — |
| Profit before tax | 15 | 605 | 684 | 747 | 0 |
| Tax | −3 | −117 | −142 | −154 | — |
| Net profit | 12 | 488 | 542 | 593 | — |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 151 | 741 | 1 089 | 1 079 | — |
| Equity | 64 | 552 | 606 | 659 | — |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 88 | 189 | 255 | 192 | — |
| Total debt | 88 | 189 | 255 | 192 | — |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20212025
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
20212025
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20212025
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
-1.00×
This company
0.62×
Market median
+261% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-02-01 – 2025-01-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-02-01 – 2024-01-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-02-01 – 2023-01-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-02-01 – 2022-01-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-02-01 – 2021-01-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2025 | |
| Former (2) | ||
| Deputy Board Member | 2022 – 2025 | |
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Laestadius Läkarkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Aina Anette Vivi-Ann Laestadius | Board of Directors | 0 companies |
| Lars Joel Laestadius | Deputy Board Member | 0 companies |
| Ragnhild D A Laestadius Norberg | Deputy Board Member | 0 companies |
| Lars Vidar Laestadius | Deputy Board Member | 0 companies |